Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.33 | N/A |
PEG Ratio (TTM) | -0.40 | N/A |
P/S Ratio (TTM) | 6.70 | N/A |
P/B Ratio (TTM) | 2.34 | N/A |
P/FCF Ratio (TTM) | -15.37 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -19.30% | N/A |
ROE (TTM) | -23.78% | N/A |
Net Profit Margin (TTM) | -71.11% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 12.51% | -766.54% | N/A |
Revenue | 4.94% | 36.20% | N/A |
Net Income | 12.02% | -77.16% | N/A |
Cash Flow | -23.57% | -59.06% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.90 | N/A |
Quick Ratio (TTM) | 2.90 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -76.67 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 1.50 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |